FENOFIBRIC ACID

Substance profile for UNII BGF9MN2HU1, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for FENOFIBRIC ACID
Structure render from PubChem CID 64929

Substance Identity#

UNII
BGF9MN2HU1
Preferred term
FENOFIBRIC ACID
Registry number
42017-89-0
EC number
255-626-9
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C17H15ClO4
Chemical structure for FENOFIBRIC ACID
Structure render from PubChem CID 64929

Chemical And Database Identifiers#

InChIKey
MQOBSOSZFYZQOK-UHFFFAOYSA-N
SMILES
CC(C)(OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2)C(O)=O
RxCUI
24852
PubChem
64929
NCIt
C83804
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound64929pubchem.ncbi.nlm.nih.gov/compound/64929
PubChem InChIKey SearchMQOBSOSZFYZQOK-UHFFFAOYSA-Npubchem.ncbi.nlm.nih.gov/#query=MQOBSOSZFYZQOK-UHFFFAOYSA-N
RxNorm24852mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=24852
NCI ThesaurusC83804ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C83804
FDA Substance Registration SystemBGF9MN2HU1precision.fda.gov/uniisearch/srs/unii/BGF9MN2HU1
European Community number255-626-9commonchemistry.cas.org/results?q=255-626-9

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE INGREDIENTThese highlights do not include all the information needed to use fenofibric acid tablets safely and effectively. See full prescribing information for fenofibric acid tablets. Fenofibric Acid Tablets, for oral use Initial U.S. Approval: 19938
ACTIVE MOIETYThese highlights do not include all the information needed to use fenofibric acid tablets safely and effectively. See full prescribing information for fenofibric acid tablets. Fenofibric Acid Tablets, for oral use Initial U.S. Approval: 19938
ACTIVE MOIETYThese highlights do not include all the information needed to use FIBRICOR ® (fenofibric acid) Tablets safely and effectively. See full prescribing information for FIBRICOR. FIBRICOR ® (fenofibric acid) Tablets, for oral use Initial U.S. Approval: 19932
ACTIVE INGREDIENTThese highlights do not include all the information needed to use FIBRICOR ® (fenofibric acid) Tablets safely and effectively. See full prescribing information for FIBRICOR. FIBRICOR ® (fenofibric acid) Tablets, for oral use Initial U.S. Approval: 19932
ACTIVE MOIETYThese highlights do not include all the information needed to use FIBRICOR ® (fenofibric acid) Tablets safely and effectively. See full prescribing information for FIBRICOR. FIBRICOR ® (fenofibric acid) Tablets, for oral use Initial U.S. Approval: 199313
ACTIVE INGREDIENTThese highlights do not include all the information needed to use FIBRICOR ® (fenofibric acid) Tablets safely and effectively. See full prescribing information for FIBRICOR. FIBRICOR ® (fenofibric acid) Tablets, for oral use Initial U.S. Approval: 199313
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Trilipix safely and effectively. See full prescribing information for Trilipix. Trilipix (fenofibric acid) capsule, delayed release for oral use Initial U.S. Approval: 20081
ACTIVE MOIETYThese highlights do not include all the information needed to use Trilipix safely and effectively. See full prescribing information for Trilipix. Trilipix (fenofibric acid) capsule, delayed release for oral use Initial U.S. Approval: 20081
ACTIVE MOIETYTRILIPIX (FENOFIBRIC ACID) CAPSULE, DELAYED RELEASE [ABBVIE INC.]1459
ACTIVE INGREDIENTTRILIPIX (FENOFIBRIC ACID) CAPSULE, DELAYED RELEASE [ABBVIE INC.]1459
ACTIVE MOIETYFENOFIBRIC ACID CAPSULE, DELAYED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]31
ACTIVE INGREDIENTFENOFIBRIC ACID CAPSULE, DELAYED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]31
ACTIVE INGREDIENTFENOFIBRIC ACID CAPSULE, DELAYED RELEASE [ZYDUS PHARMACEUTICALS USA INC]21
ACTIVE MOIETYFENOFIBRIC ACID CAPSULE, DELAYED RELEASE [ZYDUS PHARMACEUTICALS USA INC]21
ACTIVE MOIETYFENOFIBRIC ACID DELAYED-RELEASE (FENOFIBRIC ACID) CAPSULE, DELAYED RELEASE [PAR PHARMACEUTICAL, INC.]8
ACTIVE MOIETYFENOFIBRIC ACID CAPSULE, DELAYED RELEASE PELLETS [MYLAN PHARMACEUTICALS INC.]4
ACTIVE INGREDIENTFENOFIBRIC ACID CAPSULE, DELAYED RELEASE PELLETS [MYLAN PHARMACEUTICALS INC.]4
ACTIVE MOIETYFENOFIBRATE TABLET [LUPIN PHARMACEUTICALS, INC.]2
ACTIVE MOIETYFENOFIBRIC ACID TABLET [HALTON LABORATORIES]2
ACTIVE INGREDIENTFENOFIBRIC ACID TABLET [HALTON LABORATORIES]2
ACTIVE MOIETYFIBRICOR (FENOFIBRIC ACID) TABLET [TRIBUTE PHARMACEUTICALS US, INC.]2
ACTIVE INGREDIENTFIBRICOR (FENOFIBRIC ACID) TABLET [TRIBUTE PHARMACEUTICALS US, INC.]2
ACTIVE INGREDIENTFENOFIBRIC ACID CAPSULE, DELAYED RELEASE PELLETS [MYLAN INSTITUTIONAL INC.]1
ACTIVE MOIETYFENOFIBRIC ACID CAPSULE, DELAYED RELEASE PELLETS [MYLAN INSTITUTIONAL INC.]1